Abstract
Angiogenesis, the process of new blood vessel formation from preexisting ones, is critical in the development and progression of tumor. Since metastasis is favored by increased neovascularization, understanding the molecular mechanism governing angiogenesis gains utmost importance. Endothelial cells respond to numerous angiogenic factors like VEGF and switch over to angiogenic phenotype. Apart from VEGF, another key molecule involved is matrix metalloproteinases which are the enzymes involved in pericellular proteolysis, a process critically important in initiating angiogenesis. But during the later stages, when cell–cell contact formation occurs, MMP expression is downregulated. Regulation of MMPs by cell–cell contact formation was found. This article focuses on a reciprocal relationship between the expression of cell adhesion molecules that modulates cell–cell contact formation and MMP expression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anand-Apte B, Pepper M, Voest E, Iwata K, Montesano R, Olsen BR (1997) Inhibition of angiogenesis by tissue inhibitors of matrix metalloproteinases-3. Invest Ophthalmol Vis Sci 38:817–823
Anastasiadis PZ, Reynolds AB (2000) The p120 catenin family: complex roles in adhesion, signaling and cancer. J Cell Sci 113:1319–1334
Bazzoni G, Dejana E (2004) Endothelial cell to cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84:869–901
Ben-Ze’ev A, Geiger B (1998) Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer. Curr Opin Cell Biol 10:629–639
Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85:683–693
Carmeliet P, Lampugnani MG, Moons L, Breviario F, Lupu F, Herbert JM, Collen D (1999) Dejana E Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98:147–157
Chade AR, Bentley HD, Zhu X, Rodriguez-Porcel M, Niemeyer S, Amores-Arriaga B, Napolic C, Ritman EL, Lerman A, Lerman LO (2004) Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs. J Am Soc Nephrol 15:1816–1825
Charlesworth PJ, Harres AL (2006) Mechanisms of disease: angiogenesis in urologic malignancies. Nat Clin Pract Urol 3:157–169
Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, Lampugnani MG, Martin-Padura I, Stoppacciaro A, Ruco L, McDonald DM, Ward PA, Dejana E (1999) Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA 96:9815–9820
Dejana E, Bazzoni G, Lampugnani MG (1999) Vascular endothelial (VE)-cadherin: only an intercellular glue? Exp Cell Res 252:13–19
Eliceiri BP, Cheresh DA (1999) The role of alphaV integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 103:1227–1230
Fisher C, Gilbertsonbeadling S, Powers EA, Petzold G, Poorman R, Mitchell MA (1994) Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162:499–510
Folkman J (1997) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31
Gingras D, Bousquet-Gagnon N, Langois S, Lachambre MP, Annabi B, Beliveau R (2001) Activation of the extracellular signal regulated protein kinase (ERK) cascade by membrane type-1matrix metalloproteinase (MT1-MMP). FEBS Lett 507:231–236
Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364
Hass TL, Davis SJ, Madri JA (1998) Three-dimensional type I collagen lattices induce co ordinate expression of matrix metalloproteinases MT1 MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 273:3604–3610
Henriet P, Blavier L, Declerck YA (1999) Tissue inhibitors of matrix metalloproteinases in invasion and proliferation. APMIS 107:111–119
Hermann J, Lerman LO, Mukhopadhyay D, Napoli C, Lerman A (2006) Angiogenesis in atherogenesis. Thromb Vasc Biol 26:1948–1957
Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S (1998) Reduced angiogenesis and tumor progression in gelatinase A deficient mice. Cancer Res 58:1048–1051
Kiran MS, Sameer Kumar VB, Viji RI, Sudhakaran PR (2006) Temporal relationship between MMP production and angiogenic process in HUVECs. Cell Biol Inter 30:704–713
Kiran MS, Viji RI, Kumar VB, Sudhakaran PR (2008a) Modulation of angiogenic factors by ursolic acid. Biochem Biophys Res Commun 371:556–560
Kiran MS, Kumar VB, Viji RI, Sherin GT, Rajasekharan KN, Sudhakaran PR (2008b) Opposing effects of curcuminoids on serum stimulated and unstimulated angiogenic response. J Cell Physiol 215:251–264
Kiran MS, Viji RI, Kumar VB, Athira AP, Sudhakaran PR (2011) Changes in expression of VE-cadherin and MMPs in endothelial cells: Implications for angiogenesis. Vascular Cell 3:6
Koch AE, Halloran MM, Haskell CJ (1995) Angiogenesis mediated by soluble form of E selectin and vascular cell adhesion molecule 1. Nature 376:517–519
Lampugnani MG, Dejana E (1997) Interendothelial junctions: structure, signaling and functional roles. Curr Opin Cell Biol 9:674–682
Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, Ruco LP, Dejana E (1992) A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 118:1511–1522
Liao F, Li Y, O'Connor W, Zanetta L, Bassi R, Santiago A, Overholser J, Hooper A, Mignatti P, Dejana E, Hicklin DJ, Bohlen P (2000) Monoclonal antibody to vascular endothelial (VE)-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. Cancer Res 60:6805–6810
Lip GY, Blann AD (2004) Thrombogenesis, atherosclerosis, angiogenesis in vascular disease: a new “Vascular triad”. Ann Med 36:119–125
Maekawa R, Maki H, Yoshida H, Hojo K, Tanaka H, Wada T (1999) Correlation of anti angiogenic and anti tumor efficacy of N-biphenylsulfonyl phenylalanine hydroxamic acid (BPHA), an orally active, selective matrix metalloproteinase inhibitor. Cancer Res 59:1231–1235
Montesano R, Orci L (1985) Tumor promoting phorbol esters induced angiogenesis in vitro. Cell 42:469–477
Moses MA (1997) The regulation of neovascularization by matrix metalloproteinases and their inhibitors. Stem Cells 15:180–189
Moses MA, Sudhalter J, Langer R (1990) Identification of inhibitor of neovascularization from cartilage. Science 248:1408–1410
Muller WA, Gimbrone MA (1986) Plasmalemmal proteins of cultured vascular endothelial cells exhibit apical-basal polarity: analysis by surface-selective iodination. J Cell Biol 103:2389–2402
Munshi HG, Stack MS (2006) Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev 25:45–56
Naglich JG, Jure-Kunkel M, Gupta E, Fargnoli J, Henderson AJ, Lewin AC, Talbott R, Baxter A, Bird J, Savopoulos R, Wills R, Kramer RA, Trail PA (2001) Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor. Cancer Res 61:8480–8485
Nguyen M, Strubel NA, Bischoff J (1993) A role of sialyl Lewis X/A glycoconjugates in capillary morphogenesis. Nature 365:267–269
Overall CM, Lopez-Otin C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657–672
Pece S, Chiariello M, Murga C, Gutkind J (1999) Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. J Biol Chem 274:19347–19351
Pece S, Gutkind JS (2000) Signaling from E-cadherin to MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem 275:41227–41233
Qian X, Wang TN, Rothman VL, Nicosia RF, Tuszynski GP (1997) Thrombospondin-1 modulates angiogenesis in vitro by up regulation of matrix metalloproteinase-9 in endothelial cells. Exp Cell Res 235:403–412
Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674
Schnaper HW, Grant DS, Stetler Stevenson WG, Fridman R, D’Orazi G, Murphy AN (1993) Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol 156:235–246
Schwartz SM, Haudenschild CC, Eddy EM (1978) Endothelial regeneration. Quantitative analysis of initial stages of endothelial regeneration in rat aortic intima. Lab Invest 38:568–580
Seiki M, Naohiko Koshikawa, Ikuo Yana (2003) Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Metastasis Rev 22:129–143
Sholley MM, Gimbrone MA, Cotran RS (1977) Cellular migration and replication in endothelial regeneration: a study using irradiated endothelial cultures. Lab Invest 36:18–25
Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845
Simionescu M, Simionescu N (1991) Endothelial transport of macromolecules: transcytosis and endocytosis. A look from cell biology. Cell Biol Rev 25:1–78
Victor WM, van Hinsbergh MA, Engelse PHA (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arter Thromb Vasc Biol 26:716–720
Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92(8):827–839
Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D et al (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411–422
Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154
Xu Y, Guo DF, Davidson M, Inagami T, Carpenter G (1997) Interaction of the adaptor protein Shc and the adhesion molecule cadherin. J Biol Chem 272:13463–13466
Yan L, Moses MA, Huang S, Ingber DE (2000) Adhesion dependent control of matrix metalloproteinases-2 activation in human capillary endothelial cells. J Cell Sci 113:3979–3987
Yang S, Graham J, Kahn JW, Schwartz EA, Gerritsen ME (1999) Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol 155:887–895
Yu Q, Stamenkovic I (1999) Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13:35–48
Zondag GC, Reynolds AB, Moolenaar WH (2000) Receptor protein-tyrosine phosphatase RPTPmu binds to, and dephosphorylates the catenin p120(ctn). J Biol Chem 275:11264–11269
Acknowledgments
Financial assistance received from CSIR, New Delhi (MSK), and (KSCSTE), Trivandrum (AAP) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer India
About this paper
Cite this paper
Athira, A.P., Kiran, M.S., Sudhakaran, P.R. (2014). Reciprocal Relationship Between VE-Cadherin and Matrix Metalloproteinases Expression in Endothelial Cells and Its Implications to Angiogenesis. In: R. Sudhakaran, P. (eds) Perspectives in Cancer Prevention-Translational Cancer Research. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1533-2_9
Download citation
DOI: https://doi.org/10.1007/978-81-322-1533-2_9
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-1532-5
Online ISBN: 978-81-322-1533-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)